Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-002851
Filing Date
2025-03-13
Accepted
2025-03-13 07:16:12
Documents
134
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 20-F tmb-20241231x20f.htm   iXBRL 20-F 3888827
2 EX-1.1 tmb-20241231xex1d1.htm EX-1.1 236053
3 EX-4.1 tmb-20241231xex4d1.htm EX-4.1 162387
4 EX-4.4 tmb-20241231xex4d4.htm EX-4.4 23967
5 EX-4.5 tmb-20241231xex4d5.htm EX-4.5 25318
6 EX-4.6 tmb-20241231xex4d6.htm EX-4.6 132378
7 EX-4.16 tmb-20241231xex4d16.htm EX-4.16 171787
8 EX-8.1 tmb-20241231xex8d1.htm EX-8.1 8177
9 EX-11.1 tmb-20241231xex11d1.htm EX-11.1 138336
10 EX-12.1 tmb-20241231xex12d1.htm EX-12.1 13468
11 EX-12.2 tmb-20241231xex12d2.htm EX-12.2 13388
12 EX-13.1 tmb-20241231xex13d1.htm EX-13.1 16966
13 EX-15.1 tmb-20241231xex15d1.htm EX-15.1 2801
14 GRAPHIC tmb-20241231x20f001.jpg GRAPHIC 108579
15 GRAPHIC tmb-20241231x20f002.jpg GRAPHIC 53446
16 GRAPHIC tmb-20241231x20f003.jpg GRAPHIC 78015
17 GRAPHIC tmb-20241231x20f004.jpg GRAPHIC 72362
18 GRAPHIC tmb-20241231x20f005.jpg GRAPHIC 64207
19 GRAPHIC tmb-20241231xex4d1001.jpg GRAPHIC 3284
20 GRAPHIC tmb-20241231xex4d6001.jpg GRAPHIC 6371
  Complete submission text file 0001558370-25-002851.txt   16331402

Data Files

Seq Description Document Type Size
21 EX-101.SCH tmb-20241231.xsd EX-101.SCH 116488
22 EX-101.CAL tmb-20241231_cal.xml EX-101.CAL 84133
23 EX-101.DEF tmb-20241231_def.xml EX-101.DEF 357550
24 EX-101.LAB tmb-20241231_lab.xml EX-101.LAB 732478
25 EX-101.PRE tmb-20241231_pre.xml EX-101.PRE 580796
137 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20241231x20f_htm.xml XML 2887639
Mailing Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK
Business Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK 31 88 166 7000
ProQR Therapeutics N.V. (Filer) CIK: 0001612940 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-36622 | Film No.: 25733822
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)